Norinchukin Capital
VC Fund
Tokyo, Japan
Norinchukin Capital is a private equity fund management firm.
- Total investments:
- 19
- Last investment:
- Lead investor:
- 16%
Last updated:
For AI agents: llms.txt
Industries Norinchukin Capital invests in
Stages Norinchukin Capital invests in
Countries Norinchukin Capital invests in
Round sizes
Round size
- Seed
- $203k–$5.7M
- Series A
- $1.3M–$22M
- Series B
- $3.6M–$26M
Investment Focus
Industry
- FinTech 3 (16%)
- B2B 2 (11%)
- SaaS 2 (11%)
- Finance 2 (11%)
- Consulting 2 (11%)
Stage
- Series A 8 (42%)
- Seed 4 (21%)
- Series B 4 (21%)
- Series C 1 (5%)
- Funding Round 1 (5%)
Country
- Japan 14 (74%)
- India 1 (5%)
- Germany 1 (5%)
- Singapore 1 (5%)
- United Kingdom 1 (5%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
AUDER
|
AUDER is an automation service provider that helps with household inventory, ordering, smart checks, and consultancy. | $2.9M / Series A / Sep 03, 2026 | |
CheckInn
|
CheckInn is an all-in-one solution for lodging facilities that incorporates a site controller, PMS, and in-house reservation system. | $1.3M / Series A / May 13, 2026 | |
Tazapay
|
Tazapay is a global payments infrastructure platform headquartered in Singapore that enables businesses to collect, hold, and pay seamlessly across borders through a single, compliant, and scalable platform.With one integration, Tazapay provides access to local payment methods in 70+ markets, card coverage in 170+ countries, and multi-currencybusiness accounts in 35+ currencies. The platform also supports stablecoin interoperability, acting as a fiat bridge between traditional finance and digital assets, enabling businesses to adopt modern settlement methods without compromising on compliance.Tazapay’s modular offering spans checkout, virtual accounts, treasury, and payouts, with real-time routing technology for 24/7 collections and settlements in 70+ markets. Its infrastructure is built with institutional-grade compliance, fraud protection, and FX solutions, making it trusted by enterprises and platforms worldwide. | $25.5M / Series B / Mar 26, 2026 | |
Digital Securities Preparatory
|
Digital Securities Preparatory is a fintech company offering financial products to the real estate industry. | $1.9M / Series A / Dec 26, 2025 | |
Respo
|
Respo is a service that enables people to save money by buying things at a discount. | Seed / Sep 08, 2025 | |
Fermelanta
|
Fermelanta produces rare plant-based ingredients through microbial fermentation. It engineers a cell to build a biosynthetic pathway of target molecules with gene transfer and disruption. | $13.6M / Series A / Aug 29, 2025 | |
|
Tazapay
|
Tazapay is a global payments infrastructure platform headquartered in Singapore that enables businesses to collect, hold, and pay seamlessly across borders through a single, compliant, and scalable platform.With one integration, Tazapay provides access to local payment methods in 70+ markets, card coverage in 170+ countries, and multi-currencybusiness accounts in 35+ currencies. The platform also supports stablecoin interoperability, acting as a fiat bridge between traditional finance and digital assets, enabling businesses to adopt modern settlement methods without compromising on compliance.Tazapay’s modular offering spans checkout, virtual accounts, treasury, and payouts, with real-time routing technology for 24/7 collections and settlements in 70+ markets. Its infrastructure is built with institutional-grade compliance, fraud protection, and FX solutions, making it trusted by enterprises and platforms worldwide. | $10.5M / Series B / Aug 26, 2025 | |
Seeds Fincap
|
Seeds Fincap is a Delhi-based company that was incorporated as a Private Limited company. | $5.7M / Seed / Aug 12, 2025 | |
Logomix
|
Logomix Inc is a mammalian cellular genome architect startup. Logomix proprietary platform, Geno-Writing™, technology integrates large-scale (Mb) human genome-writing technologies and providing genetically architected versatile human cells and/or downsized cells and microbes for drug development and cell & gene therapy area.Majority ofthe cell engineering companies are currently focused on optimization of gene clusters by automatic high throughput system however, Logomix’s Geno-Writing™ provides the required tools for dealing with mammalian or complex genomes. Logomix works with partners by providing new biology-based solutions to co-create business and social values on Geno-Writing™ platform Current Focus Area includes: 1. Human Health & Therapeutics 2. Biomaterials & Chemicals 3. Agriculture & EnvironmentLogomix has 11 ongoing collaborative research partnerships. Currently Logomix is specifically looking for industry partners to address unmet needs in neurodegenerative disease areas. | $18.8M / Jul 30, 2025 | |
Terass
|
TERASS is a High-end real estate information site. | $13.4M / Series C / Jul 30, 2025 | |
| See all 19 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Norinchukin Capital invest in?
Norinchukin Capital invests primarily in FinTech, B2B and SaaS startups, most often at Series A and Seed stage. Most of the 19 investments tracked by Shizune back companies in Japan. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Norinchukin Capital's check size?
Norinchukin Capital typically joins rounds of $203k–$5.7M at Seed, $1.3M–$22M at Series A and $3.6M–$26M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Norinchukin Capital participates in.
When did Norinchukin Capital last invest?
The most recent investment recorded for Norinchukin Capital closed in Sep 2026. Shizune tracks 19 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
